Comprehensive evaluation of the adenovirus/alphavirus-replicon chimeric vector-based vaccine rAdV-SFV-E2 against classical swine fever

Vaccine

Volumn 31, Issue 3, 2013, Pages 538-544

  Sun, Yuan ^a   Tian, Da Yong ^a   Li, Su ^a   Meng, Qi Lin ^a   Zhao, Bi Bo ^a   Li, Yongfeng ^a   Li, Dan ^a   Ling, Li Jun ^a   Liao, Ya Jin ^a   Qiu, Hua Ji ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

Chimeric vectored vaccine; Classical swine fever; Efficacy; Safety

Indexed keywords

ADENOVIRUS VECTOR; MATERNAL ANTIBODY; PSEUDORABIES VACCINE; RADV SFV E2 VACCINE; RNA VACCINE; UNCLASSIFIED DRUG;

ADENOVIRUS; ALPHA VIRUS; ANIMAL EXPERIMENT; ARTICLE; CLASSICAL SWINE FEVER; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; GENE EXPRESSION; IMMUNITY; IMMUNIZATION; INFECTION PREVENTION; LOW DRUG DOSE; MOUSE; NONHUMAN; PESTIVIRUS; PRIORITY JOURNAL; RABBIT; SWINE; VIRAL GENE DELIVERY SYSTEM; VIRUS REPLICATION; VIRUS STRAIN;

ADENOVIRIDAE; ANIMALS; CLASSICAL SWINE FEVER; GENETIC VECTORS; MICE; MICE, INBRED BALB C; RABBITS; SEMLIKI FOREST VIRUS; SWINE; VACCINES, MARKER; VACCINES, SYNTHETIC; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 84871669334     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.11.013     Document Type: Article

References (20)

1. Moennig V., Floegel-Niesmann G., Greiser-Wilke I. Clinical signs and epidemiology of classical swine fever: a review of new knowledge. Vet J 2003, 165(1):11-20.
2. de Smit A.J., van Gennip H.G., Miedema G.K., van Rijn P.A., Terpstra C., Moormann R.J. Recombinant classical swine fever (CSF) viruses derived from the Chinese vaccine strain (C-strain) of CSF virus retain their avirulent and immunogenic characteristics. Vaccine 2000, 18(22):2351-2358.
3. Biront P., Leunen J., Vandeputte J. Inhibition of virus replication in the tonsils of pigs previously vaccinated with a Chinese strain vaccine and challenged oronasally with a virulent strain of classical swine fever virus. Vet Microbiol 1987, 14(2):105-113.
4. Terpstra C., Woortmeyer R., Barteling S.J. Development and properties of a cell culture produced vaccine for hog cholera based on the Chinese strain. Dtsch Tierarztl Wochenschr 1990, 97(2):77-79.
5. Graham S.P., Everett H.E., Haines F.J., Johns H.L., Sosan O.A., Salguero F.J., et al. Challenge of pigs with classical swine fever viruses after C-strain vaccination reveals remarkably rapid protection and insights into early immunity. PLoS ONE 2012, 7(1):e29310.
6. Wensvoort G., Terpstra C., de Kluyver E.P. Characterization of porcine and some ruminant pestiviruses by cross-neutralization. Vet Microbiol 1989, 20(4):291-306.
7. van Oirschot J.T. Vaccinology of classical swine fever: from lab to field. Vet Microbiol 2003, 96(4):367-384.
8. Suradhat S., Intrakamhaeng M., Damrongwatanapokin S. The correlation of virus-specific interferon-gamma production and protection against classical swine fever virus infection. Vet Immunol Immunopathol 2001, 83(3-4):177-189.
9. Beer M., Reimann I., Hoffmann B., Depner K. Novel marker vaccines against classical swine fever. Vaccine 2007, 25(30):5665-5670.
10. Reimann I., Depner K., Trapp S., Beer M. An avirulent chimeric pestivirus with altered cell tropism protects pigs against lethal infection with classical swine fever virus. Virology 2004, 322(1):143-157.
11. Koenig P., Lange E., Reimann I., Beer M. CP7_E2alf: a safe and efficient marker vaccine strain for oral immunisation of wild boar against classical swine fever virus (CSFV). Vaccine 2007, 25(17):3391-3399.
12. Leifer I., Lange E., Reimann I., Blome S., Juanola S., Duran J.P., et al. Modified live marker vaccine candidate CP7_E2alf provides early onset of protection against lethal challenge infection with classical swine fever virus after both intramuscular and oral immunization. Vaccine 2009, 27(47):6522-6529.
13. König P., Blome S., Gabriel C., Reimann I., Beer M. Innocuousness and safety of classical swine fever marker vaccine candidate CP7_E2alf in non-target and target species. Vaccine 2011, 30(1):5-8.
14. Gabriel C., Blome S., Urniza A., Juanola S., Koenen F., Beer M. Towards licensing of CP7_E2alf as marker vaccine against classical swine fever-duration of immunity. Vaccine 2012, 30(19):2928-2936.
15. Blome S., Aebischer A., Lange E., Hofmann M., Leifer I., Loeffen W., et al. Comparative evaluation of live marker vaccine candidates " CP7_E2alf" and " flc11" along with C-strain " Riems" after oral vaccination. Vet Microbiol 2012, 158(1-2):42-59.
16. Sun Y., Li H.Y., Tian D.Y., Han Q.Y., Zhang X., Li N., et al. A novel alphavirus replicon-vectored vaccine delivered by adenovirus induces sterile immunity against classical swine fever. Vaccine 2011, 29(46):8364-8372.
17. Zhao J.J., Cheng D., Li N., Sun Y., Shi Z., Zhu Q.H., et al. Evaluation of a multiplex real-time RT-PCR for quantitative and differential detection of wild-type viruses and C-strain vaccine of Classical swine fever virus. Vet Microbiol 2008, 126(1-3):1-10.
18. Peng W.P., Hou Q., Xia Z.H., Chen D., Li N., Sun Y., et al. Identification of a conserved linear B-cell epitope at the N-terminus of the E2 glycoprotein of Classical swine fever virus by phage-displayed random peptide library. Virus Res 2008, 135(2):267-272.
19. Terpstra C. Hog cholera: an update of present knowledge. Br Vet J 1991, 147(5):397-406.
20. Vandeputte J., Too H.L., Ng F.K., Chen C., Chai K.K., Liao G.A. Adsorption of colostral antibodies against classical swine fever, persistence of maternal antibodies, and effect on response to vaccination in baby pigs. Am J Vet Res 2001, 62(11):1805-1811.